PDF-sejcഌd༐a༌velᐓrdᔍtel

Author : karlyn-bohler | Published Date : 2016-03-12

suux0304rix0307ys Mcx0D0Cdx0F10ylx1519lx031Atex100Dallsfx1911cx100E x1B1CajjlCell x0316cx210Cx220ClctylCx100C

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "sejcഌd༐a༌velᐓ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

sejcഌd༐a༌velᐓrdᔍtel: Transcript

suux0304rix0307ys Mcx0D0Cdx0F10ylx1519lx031Atex100Dallsfx1911cx100E x1B1CajjlCell x0316cx210Cx220ClctylCx100C. Nyokum܈the,aiญfsvlic wᔒrܒsvcᔒᔃdvnܘvᔍly wᔒrܒsvcᔒᔃdvnܘvᔍly NyoЅ؇ the ،in feဉ Mōa؇mi xଉRu̎༏ Moreaeleyam DmauP̅ܓ̑ᐔई̕ᐓmuh̅ई̗᠈̙ahRk̕ᐓmuh̔&# ᔍȈ܋̂Іᘒᜐ᠒ El̄nor White May ༐ , 2ሓ EЇthwormᜈhИe four h̄rt᜛ All of th̖ have onl� ceᘊl༌mᘏ/her: ceᘊl༌mᘏ/her: mxeᘋΓ༉mᰑβ/pp=mΓrpΓᤑdrS/lΩe᠌༙/0ᘑ. mxeᘋ� Name: Date: Cal਋late the p༐fit o༌loጓ fo༌ea਍ of theጄ ̐ney-maᜒng ideaጚ Reme̜e༅ Revenue ᘌ Expen& Versatile . Efficient. . and. . Longer. Wagon . for. European Transportation. Dipl.-Ing. A. Carrillo Zanuy. EC FP7-SST-2010-RTD-1. Collaborative Project, Nr. 265610. Duration: 25 M . (01.12.2010-31.12.2012). 400/100 mg . qd. N = 500. N = 100. W12. Placebo. >. 18 years. Chronic HCV infection. Genotype 1, 2, 4, 5 or 6. Naïve or pre-treatment. with IFN-based regimen. Compensated cirrhosis allowed**. No HBV or HIV co-infection. ĂpЅtaࠉe CĊMIN᠙ ᔁਚ਋᠙ JUĊSᜊCഊON WĊഌP།਍ਕN (CRL.) NO.129 ᔖ 2015 ┇kub &# KisiЅt Kis’ࠂF Kiࠊ KiЋy Kംࠎyyt KംЇt Kംt’ K഍n’ymo Kഐyn KഌniА Kഌndmi Kഌ� N = 69. >. 18 years. Failure to SOF/VEL . or SOF/VEL + VOX . (LEPTON study). Any genotype. Compensated cirrhosis allowed. No HBV or HIV co-infection. Open-label. SOF/VEL: 400/100 mg FDC QD ; RBV: weight based in twice daily dose . . and. . Longer. Wagon . for. European Transportation. Dipl.-Ing. A. Carrillo Zanuy. EC FP7-SST-2010-RTD-1. Collaborative Project, Nr. 265610. Duration: 25 M . (01.12.2010-31.12.2012). 4 Partners: . W24. SOF/VEL. >. 18 years. Chronic HCV infection. Genotype 1 to 6. Naïve or treatment-experienced. No prior treatment with . NS5A or NS5B inhibitor. Child-Pugh B cirrhosis **. No . hepatocellular. 1 2 - 32 MHz Low VSWR 121 Maximum Deviation from 90Impedance 50 Ohms Nom Input Power 1 W Max Guaranteed Specifications From 55oC to 85oFrequency Range 2 - 32 MHz Insertion Loss less coupling Isolatio >. 18 years. Genotype 2, 3, 4, 5 or 6. HCV RNA . >. 10 000 IU/mL. Treatment-naive or treatment-experienced (with or without DAA). Compensated cirrhosis allowed. Creatinine clearance . >. 60 mL/min.

Download Document

Here is the link to download the presentation.
"sejcഌd༐a༌velᐓrdᔍtel"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.